These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33042029)

  • 1. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.
    Holly JMP; Biernacka K; Maskell N; Perks CM
    Front Endocrinol (Lausanne); 2020; 11():582870. PubMed ID: 33042029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19.
    Hanchard J; Capó-Vélez CM; Deusch K; Lidington D; Bolz SS
    Front Endocrinol (Lausanne); 2020; 11():583006. PubMed ID: 33101215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and COVID-19.
    Azzolino D; Cesari M
    Front Endocrinol (Lausanne); 2020; 11():581356. PubMed ID: 33101213
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes and COVID-19: Global and regional perspectives.
    Jeong IK; Yoon KH; Lee MK
    Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
    Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, infection risk and COVID-19.
    Erener S
    Mol Metab; 2020 Sep; 39():101044. PubMed ID: 32585364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus infection in patients with diabetes.
    Torres-Tamayo M; Caracas-Portillo NA; Peña-Aparicio B; Juárez-Rojas JG; Medina-Urrutia AX; Martínez-Alvarado MDR
    Arch Cardiol Mex; 2020; 90(Supl):67-76. PubMed ID: 32523141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: a storm is raging.
    Pedersen SF; Ho YC
    J Clin Invest; 2020 May; 130(5):2202-2205. PubMed ID: 32217834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
    Ortiz-Prado E; Simbaña-Rivera K; Gómez-Barreno L; Rubio-Neira M; Guaman LP; Kyriakidis NC; Muslin C; Jaramillo AMG; Barba-Ostria C; Cevallos-Robalino D; Sanches-SanMiguel H; Unigarro L; Zalakeviciute R; Gadian N; López-Cortés A
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115094. PubMed ID: 32623267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.